Obe­si­ty drug de­vel­op­er Met­sera and kid­ney dis­ease biotech Maze Ther­a­peu­tics priced their Nas­daq IPOs on Thurs­day evening.

Experience movie monsters from the studio that invented the horror genre. Experience some of the scariest monsters in the world in this immensely themed year-round maze. Based off Universal’s long and ...

Daiichi Sankyo’s board of directors followed the nomination committee’s report in making the appointment. Credit: ArDanMe/Shutterstock. Daiichi Sankyo has announced that Hiroyuki Okuzawa will succeed ...

Vertex has set the therapy’s wholesale acquisition cost at $15.50 per 50mg pill. Credit: © 2025 Vertex Pharmaceuticals Incorporated. All Rights Reserved. The US ...

Even tenants who make a point of standing up for their rights can still find themselves at the mercy of power dynamics in Toronto’s precarious housing system. Amelia, a 26-year-old who moved here last ...

Drug developer Maze Therapeutics said on Monday it was targeting a valuation of up to $728.1 million in its New York initial public offering, set to be the first U.S.-based biotech firm to debut this ...

Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a phase 2 trial. The Bay Area-based biotech unveiled its ambition earlier ...

The concave “ski slope” lugs are the signature feature of the Maze III’s brand-new case. Farer The case is also an entirely different shape. It’s now a more traditional round shape with more detailed ...

The final round of the 2025 American Express begins Sunday, Jan. 19, at PGA West in La Quinta, Calif. Here’s everything you need to know to watch the tournament on Sunday, including full ...

Older Canberrans will remember the wooden maze, built in 1979 by local public servant Peter Batum as part of the Department of the Capital Territory’s effort to turn Weston Park into a major ...